Cipryan Lukas, Litschmannova Martina, Maffetone Philip B, Plews Daniel J, Dostal Tomas, Hofmann Peter, Laursen Paul B
Department of Human Movement Studies & Human Motion Diagnostic Centre, The University of Ostrava, Ostrava, Czechia.
Department of Applied Mathematics, VSB-Technical University of Ostrava, Ostrava, Czechia.
Front Nutr. 2022 May 23;9:867690. doi: 10.3389/fnut.2022.867690. eCollection 2022.
This randomized controlled parallel-group study examined the effects of a very low-carbohydrate high-fat (VLCHF) diet and high-intensity interval training (HIIT) program over 12-weeks on cardiometabolic risk factors in individuals with overfat constitution.
Ninety-one participants out of 109 completed the study. The participants were randomly allocated to the HIIT ( = 22), VLCHF ( = 25), VLCHF+HIIT ( = 25), or control ( = 19) groups for 12 weeks. Fasting plasma samples were collected before the intervention and after 4 and 12 weeks. The analyzed outcomes included complete blood count, glucose, insulin, glycated hemoglobin, triglycerides (TG), cholesterol, high- and low-density lipoprotein (HDL-C and LDL-C), lipoprotein(a), adiponectin (Adpn), leptin (Lep), tumor necrosis factor α (TNF-α), other interleukins (hs-IL-6, IL-1β, and IL-10), and IL-1RA. The homeostasis model assessment of insulin resistance (HOMA-IR), Adpn/Lep ratio, TG/HDL-C ratio, and TyG index were calculated and analyzed. Blood pressure was measured before the intervention, after 4, 8, and 12 weeks (ClinicalTrials.gov: NCT03934476).
Absolute changes in HOMA-IR, Adpn/Lep ratio, LDL-C, and diastolic blood pressure after 12 weeks differed by study groups ( < 0.05). The most pronounced changes were revealed in the VLCHF (ΔM [95% CI]; HOMA-IR: -0.75 [-1.13; -0.55]; Adpn/Lep: 9.34 [6.33; 37.39]; LDL-C: 0.06 [-0.12; 0.50] mmol/l) and VLCHF+HIIT (HOMA-IR: -0.44 [-1.14; 0.12]; Adpn/Lep: 4.26 [2.24; 13.16]; LDL-C: 0.25 [-0.04; 0.50] mmol/l) groups.
A 12-week VLCHF diet intervention in individuals with overfat constitution is effective for favorable changes in HOMA-IR (compared to HIIT), Adpn/Lep ratio, and diastolic blood pressure. HIIT, or HIIT combined with the VLCHF diet, had no additional benefits for the analyzed variables. No adverse side effects were observed.
本随机对照平行组研究探讨了为期12周的极低碳水化合物高脂肪(VLCHF)饮食和高强度间歇训练(HIIT)计划对超重个体心血管代谢危险因素的影响。
109名参与者中有91名完成了研究。参与者被随机分配到HIIT组(n = 22)、VLCHF组(n = 25)、VLCHF+HIIT组(n = 25)或对照组(n = 19),为期12周。在干预前以及4周和12周后采集空腹血浆样本。分析的结果包括全血细胞计数、血糖、胰岛素、糖化血红蛋白、甘油三酯(TG)、胆固醇、高密度和低密度脂蛋白(HDL-C和LDL-C)、脂蛋白(a)、脂联素(Adpn)、瘦素(Lep)、肿瘤坏死因子α(TNF-α)、其他白细胞介素(hs-IL-6、IL-1β和IL-10)以及IL-1RA。计算并分析胰岛素抵抗稳态模型评估(HOMA-IR)、Adpn/Lep比值、TG/HDL-C比值和TyG指数。在干预前、4周、8周和12周后测量血压(ClinicalTrials.gov:NCT03934476)。
12周后,HOMA-IR、Adpn/Lep比值、LDL-C和舒张压的绝对变化因研究组而异(P < 0.05)。VLCHF组(ΔM [95% CI];HOMA-IR:-0.75 [-1.13;-0.55];Adpn/Lep:9.34 [6.33;37.39];LDL-C:0.06 [-0.12;0.50] mmol/l)和VLCHF+HIIT组(HOMA-IR:-0.44 [-1.14;0.12];Adpn/Lep:4.26 [2.24;13.16];LDL-C:0.25 [-0.04;0.50] mmol/l)的变化最为显著。
对于超重个体,为期12周的VLCHF饮食干预对HOMA-IR(与HIIT相比)、Adpn/Lep比值和舒张压产生有利变化有效。HIIT或HIIT与VLCHF饮食联合使用,对所分析的变量没有额外益处。未观察到不良副作用。